Similar Search Results

Firm level profitability determinants in Indian drugs and pharmaceutical industry

Tyagi, Shilpi; Nauriyal, D. K. - In: International journal of pharmaceutical and healthcare … 11 (2017) 3, pp. 271-290

Persistent link: https://www.econbiz.de/10011799086

India - Patent Protection for Pharmaceutical and Agricultural Chemical Products - Complaint by the European Communities and their Member States : Report of the Panel

World Trade Organization - 1998

On 28 April 1997, the EC requested consultations with India in respect of the alleged absence in India of patent … with India’s obligations under Article 70, paragraphs 8 and 9, of the TRIPS Agreement (see similar US complaint in WT/DS50 …

Persistent link: https://www.econbiz.de/10012884255

India - Patent Protection for Pharmaceutical and Agricultural Chemical Products : Report of the Appellate Body

World Trade Organization - 1997

On 7 April 1997, the US requested consultations with Japan in respect of the latter’s prohibition, under quarantine measures, of imports of certain agricultural products. The US alleged that Japan prohibits the importation of each variety of a product requiring quarantine treatment until the...

Persistent link: https://www.econbiz.de/10012884319

India - Patent Protection for Pharmaceutical and Agricultural Chemical Products : Report of the Panel

World Trade Organization - 1997

Persistent link: https://www.econbiz.de/10012884337

Competitive Advantage in New Patent Regime : A Study of the Indian Pharmaceutical Industry

Singh, Abhinava - 2019

The introduction of product patent regime in 2005 forced the firms in the Indian Pharmaceutical Industry (IPI) to rethink their sources of competitive advantage. The absence of an appropriate funding mechanism through the Indian government and the acquisition of Indian pharmaceutical firms by...

Persistent link: https://www.econbiz.de/10014170842

Injunctions in Indian Pharmaceutical Patent Infringement Actions : Some Observations

Rathod, Sandeep - 2016

India’s most recent tryst with pharmaceutical product patents is eleven years old. These years have seen a number of …) Undertakings for non-commercialisation given by generic companies also act/stand on same footing as injunctions; and e) India will …

Persistent link: https://www.econbiz.de/10014128192

The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies

Sundaramoorthy, Sriramkumar; Yerram, Chandra Bindu; … - 2016

snapshot of the biotech industry in India today. It will serve as a baseline for the scenario in future. (Article freely …

Persistent link: https://www.econbiz.de/10014129813

Patent Holdings of Indian Pharmaceutical and Biotechnology Companies in International Markets of Different Sizes

Sebastian, Teena; Pattnayak, Jyothi; Soby, Sajna; … - 2016

In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we identify the number of patents assigned by four foreign governments to Indian pharmaceutical and biotechnological companies up to December 31, 2009. It is known that the United...

Persistent link: https://www.econbiz.de/10014130598

Patent Maintenance by Indian Pharma and Bio-Pharma Companies

Kumari, Sangita; Saberwal, Gayatri - 2016

Patents are important for biotechnology and pharmaceutical companies. In order to remain valid, an issued patent has to be ‘maintained’ by the payment of fees to the patent office at three well-defined times over several years. The article examines whether Indian companies in these sectors...

Persistent link: https://www.econbiz.de/10014130632

Effects of Trips Agreement on Indian Pharmaceutical Patenting

Pai, Rimpa - 2023

The TRIPS Agreement obligated India to amend its patent laws to meet the minimum standard of patent protection and … patentability. In 2005, India amended its Patent Act to comply with TRIPS, which resulted in the removal of several provisions that … India. It discusses the challenges faced by the Indian pharmaceutical industry and the strategies adopted by India to …

Persistent link: https://www.econbiz.de/10014347932